Joseph G. Maliakkal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Joseph G. Maliakkal has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Jie Zheng
Department of Radiology, The First Affiliated Hospital of Xi’an Jiaotong University, 277# West Yanta Road, Xi’an, 710061, Shaanxi Province, China
2 shared publications - Vikas R. Dharnidharka
Department of Pediatrics Rutgers Robert Wood Johnson Medical School and Bristol‐Myers‐Squibb Children's Hospital New Brunswick New Jersey USA
2 shared publications Charles Goss
Department of Biostatistics, Washington University in St. Louis School of Medicine, St. Louis, MO, USA
1 shared publicationD. Fong
Washington University, St. Louis
1 shared publicationDaniel C. Brennan
Division of Nephrology, Department of Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO, USA
1 shared publication- Daniel C. Brennan
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
1 shared publication
Latest Publications
- Open Access
- 18 November 2016
- Published by Frontiers Media SA in Transplant International
- Vol. 30 (2) , 153-161
Ureteral stent placement and immediate graft function are associated with increased risk of BK viremia in the first year after kidney transplantation
Ureteral stent (UrSt) placement has been shown to be a significant independent risk factor for BK viruria, viremia, and BK virus nephropathy. We assessed whether this observation could be validated at our high volume kidney transplant center that has had a strong historical focus on BK virus nephropathy detection. We performed a retrospective case–control study of adults receiving a kidney‐only transplant and followed for 1 year between 2004 and 2011 with uniform immunosuppression and use of blood BK virus PCR screening protocol. Among 1147 patients, 443 (38.6%) received a UrSt and 17.2% with a UrSt had BK viremia versus 13.5% without stent (odds ratio 1.33; 95% CI: 1.00–1.78). We confirmed a previously reported association between immediate graft function (IGF) and higher rate of BK viremia (15.7% vs. 5.9% in patients without IGF). On multivariable competing risks Cox regression in patients with IGF, UrSt (adjusted hazard ratio [aHR] 1.35; 95% CI: 1.04–1.75) and African American race (aHR 1.47; 95% CI: 1.04–2.09) significantly increased the risk for BK viremia. In the largest sample size to date, we confirmed that UrSt placement during kidney transplant surgery is a risk factor for BK viremia within the first year post‐transplant and that IGF is associated with BK viremia.
- 18 November 2016
- Published by Frontiers Media SA in Transplant International
- Vol. 30 (2) , 153-161
Open AccessUreteral stent placement and immediate graft function are associated with increased risk of BK viremia in the first year after kidney transplantation
Ureteral stent (UrSt) placement has been shown to be a significant independent risk factor for BK viruria, viremia, and BK virus nephropathy. We assessed whether this observation could be validated at our high volume kidney transplant center that has had a strong historical focus on BK virus nephropathy detection. We performed a retrospective case–control study of adults receiving a kidney‐only transplant and followed for 1 year between 2004 and 2011 with uniform immunosuppression and use of blood BK virus PCR screening protocol. Among 1147 patients, 443 (38.6%) received a UrSt and 17.2% with a UrSt had BK viremia versus 13.5% without stent (odds ratio 1.33; 95% CI: 1.00–1.78). We confirmed a previously reported association between immediate graft function (IGF) and higher rate of BK viremia (15.7% vs. 5.9% in patients without IGF). On multivariable competing risks Cox regression in patients with IGF, UrSt (adjusted hazard ratio [aHR] 1.35; 95% CI: 1.04–1.75) and African American race (aHR 1.47; 95% CI: 1.04–2.09) significantly increased the risk for BK viremia. In the largest sample size to date, we confirmed that UrSt placement during kidney transplant surgery is a risk factor for BK viremia within the first year post‐transplant and that IGF is associated with BK viremia.
- 15 July 2014
- Published by Wolters Kluwer Health in Transplantation
- Vol. 98, 553
Ureteral Stent Placement Increases the Risk of BK Viremia in the First Year After Kidney Transplantation: A Validation Study.
- 15 July 2014
- Published by Wolters Kluwer Health in Transplantation
- Vol. 98, 553
Ureteral Stent Placement Increases the Risk of BK Viremia in the First Year After Kidney Transplantation: A Validation Study.